Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 2Available 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Expanded_access 1

Sponsor

Cancer Type

Endocrine 3

Conditions

Glioma 12Glioblastoma 6Insulinoma 4Hypoglycemia 4Congenital Hyperinsulinism 4Brain Neoplasms 4Neuroendocrine Tumors 3Neuroblastoma 3Hyperinsulinism 3Recurrence 2Pheochromocytoma 2Parkinson Disease 2Oligodendroglioma 2Gliosarcoma 2Ependymoma 2Carcinoid Tumor 2Astrocytoma 2Thyroid cancer, medullary 1Sarcoma 1Parkinsonian Disorders 1Parathyroid Neoplasms 1Paraganglioma 1Optic Nerve Glioma 1Neoplasms, Neuroepithelial 1Neoplasms 1Multiple Endocrine Neoplasia 1Lewy Body Disease 1Infant, Newborn, Diseases 1Hyperparathyroidism 1Hypercalcemia 1

Interventions

fluorodopa F 18 3Metformin 3Clomiphene 2pasireotide 1dapagliflozin 1amino-acid, glucose, and electrolyte solution 1Surveys and Questionnaires 1Sugars 1Solutions 1Saline Solution 1Pioglitazone 1Insulin 1Injections 1Diazoxide 1Amino Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Hyperinsulinism × fluorodopa F 18 × Clear all
NCT01916148 2026-04-27

18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia

Children's Hospital of Philadelphia

Available
Endocrine

Beckwith-Wiedemann Syndrome, Hyperinsulinism, Hypoglycemia, Insulinoma, Congenital Hyperinsulinism

NCT05088798 2025-12-19

18FDOPA HI

Washington University School of Medicine

Phase 2 Recruiting
100 enrolled
Endocrine

Hyperinsulinism, Hypoglycemia, Infant, Newborn, Diseases, Insulinoma, Glucose Metabolism Disorders

NCT02021604 2024-07-16

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

Cook Children's Health Care System

Phase 1 Recruiting
250 enrolled
Endocrine

Hyperinsulinism, Hypoglycemia, Insulinoma, Congenital Hyperinsulinism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡